Medifast (MED) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $13.15 +4.45%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
ARIS, COHR, ATS, More
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
ARIS, COHR, ATS, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $2.36, $0.02 worse than the analyst estimate of $2.38. Revenue for the quarter came in at $264.9 million versus the consensus estimate of $244.49 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- Amcor plc (AMCR) Misses Q1 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
